Statement on malignant mesothelioma in the United Kingdom.
D001194:Asbestos / Q000009:adverse effects*; D003937:Diagnosis, Differential; D006801:Humans; D015994:Incidence; D008175:Lung Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D008487:Medical History Taking; D008654:Mesothelioma / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D009367:Neoplasm Staging / Q000379:methods; D009784:Occupational Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010997:Pleural Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011379:Prognosis; D012017:Referral and Consultation; D016019:Survival Analysis; D014057:Tomography, X-Ray Computed; D014942:Workers' Compensation
D001194:Asbestos